Incyte
INCY
#1059
Rank
HK$183.10 B
Marketcap
HK$916.53
Share price
2.68%
Change (1 day)
70.58%
Change (1 year)

EPS for Incyte (INCY)

EPS in 2026 (TTM): HK$57.03

According to Incyte's latest financial reports the company's current EPS (TTM) is HK$57.25. In 2025 the company made an earnings per share (EPS) of HK$51.76 an increase over its 2024 EPS that were of HK$2.43.

EPS history for Incyte from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)HK$57.0310.18%
2025HK$51.762029.03%
2024HK$2.43-88.39%
2023HK$20.9473.38%
2022HK$12.08-64.1%
2021HK$33.65-408.63%
2020-HK$10.90-166.83%
2019HK$16.31300%
2018HK$4.08-133.33%
2017-HK$12.24-378.57%
2016HK$4.392700%
2015HK$0.16-106.67%
2014-HK$2.35-44.44%
2013-HK$4.2450%
2012-HK$2.82

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
HK$55.06-3.84%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$10.27-82.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$221.37 286.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$113.57 98.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
HK$49.41-13.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
-HK$1.02-101.78%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-HK$4.55-107.95%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
-HK$6.59-111.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-HK$1.80-103.15%๐Ÿ‡บ๐Ÿ‡ธ USA